At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled / 15 target
Drug / intervention
transcranial magnetic stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Accelerated Intermittent Theta Burst Stimulation to a Novel DLPFC Target for Anxiety and Trauma-related Disorders: a Pilot Study
In Brief
A clinical study evaluating transcranial magnetic stimulation for Anxiety Symptoms and Anxiety Disorders. Completed, enrolled 15 participants across 1 site.
Detailed Summary
The present pilot study will apply accelerated intermittent theta burst stimulation (aiTBS) to a novel transcranial magnetic stimulation (TMS) target for anxiety derived via causal network mapping.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnxiety Symptoms, Anxiety Disorders
CountriesChina
CollaboratorsBrigham and Women's Hospital
Timeline
N/ACompletedFinished
20252026
Enrollment StartJun 2024
First PostedJun 2024
Primary CompletionApr 2025
TodayJul 2026
First PostedJun 26, 2024
Enrollment StartJun 19, 2024
Primary CompletionApr 13, 2025
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.0 years ago
Arms & Interventions
Open-label aiTBS to novel right dmPFC TMS anxiety targetexperimental
Device: transcranial magnetic stimulation
Interventions
transcranial magnetic stimulationdevice
non-invasive form of brain stimulation accelerated intermittent theta burst stimulation (aiTBS)